102 related articles for article (PubMed ID: 6145634)
21. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
22. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
23. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
24. Serum concentration of bile acids in relation to the normal menstrual cycle the administration or oral contraceptives, and pregnancy.
Jones DE; Miranda R; Wolfe M; Demers LM
Am J Obstet Gynecol; 1978 Mar; 130(5):593. PubMed ID: 629318
[TBL] [Abstract][Full Text] [Related]
25. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
27. Zinc and copper nutriture of women taking oral contraceptive agents.
Vir SC; Love AH
Am J Clin Nutr; 1981 Aug; 34(8):1479-83. PubMed ID: 6791490
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
29. Serum bile acid in the evaluation of colchicine treatment of carbon tetrachloride-induced liver injury.
Bolarin DM
Exp Mol Pathol; 1984 Dec; 41(3):384-9. PubMed ID: 6510512
[TBL] [Abstract][Full Text] [Related]
30. Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
Wiik P; Nordby J; Paulsen JE
Acta Obstet Gynecol Scand; 1993 Oct; 72(7):550-5. PubMed ID: 8213103
[TBL] [Abstract][Full Text] [Related]
31. Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Ruokonen A; Lund L; Nummi S; Alapiessa U; Viinikka L
Eur J Obstet Gynecol Reprod Biol; 1982 Jun; 13(4):259-65. PubMed ID: 6214438
[TBL] [Abstract][Full Text] [Related]
32. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
33. Effects of short-term treatment with a combined oestrogen-progestin oral contraceptive on biliary lipids and cholesterol saturation index in young women.
Snowball S; Taylor W
J Steroid Biochem; 1985 Feb; 22(2):257-61. PubMed ID: 3982033
[TBL] [Abstract][Full Text] [Related]
34. Metabolic changes during treatment with two different progestogens.
Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
[TBL] [Abstract][Full Text] [Related]
37. Severe and prolonged oral contraceptive jaundice.
Lieberman DA; Keeffe EB; Stenzel P
J Clin Gastroenterol; 1984 Apr; 6(2):145-8. PubMed ID: 6715853
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoassay of serum conjugated cholic acid in hepatic murine schistosomiasis.
Bolarin DM
Trans R Soc Trop Med Hyg; 1984; 78(6):755-7. PubMed ID: 6533847
[TBL] [Abstract][Full Text] [Related]
39. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
40. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]